Future [18F]FE-PE2I PET studies should focus on the prodromal (rapid eye movement sleep behaviour disorder and other non-motor presentation) stage of the disease, as well as on the trajectory of DAT loss from longer follow-up of patients in more advanced stages of Parkinson’s disease. The gene discussed is SLC6A3; the disease is Parkinson disease.